Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Paulette Mehta

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Med, College of Medicine
DivisionInternal Med Hem-Onc
Address6C/117 VA Little Rock
4300 W. 7th
Mail Slot # 508
Little Rock AR 72205
Phone501-257-4542
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentPediatrics, College of Medicine


    Collapse Biography 
    Collapse Leadership and Administrative Roles
    Chairperson, Blood Utilization Committee, CAVHS, LR, AR

    Co-Editor-in-Chief, Medicine and Meaning,

    Director, Narrative Medicine Program, UAMS

    Leader, meditation program, CAVHS,

    Member, Field Advisory Committee, VA Central Office, Washington DC, (previously Chairperson of Committee, ~ 2010-2015)

    Member, AVAHO (Association of VA Hematologists/Oncologists), previously president 2010-2012

    Collapse awards and honors
    2021"Successful Aging": List of most impactful articles and book chapters 2020-2021, Springer Nature 2020 Highights

    Collapse Teaching 
    Collapse teaching overview
    I teach clinical hematology/oncology residents and fellows during my rotations on clinical service, every 3-4 months


    Collapse Research 
    Collapse research activities and funding
    R24MD002805     (HENRY-TILLMAN, RONDA S)Jul 1, 2008 - Mar 31, 2014
    NIH
    Colorectal Cancer Education and Screening Program (CCESP)
    Role: Co-Investigator
    N01 CN25140     (MEHTA, PAULETTE)Oct 1, 2004 - Jun 30, 2008
    NIH/Nat. Cancer Institute - Pass Through: Cleveland Clinic Foundation
    Phase IIb Randomized Placebo-Controlled Trail of an NSAID for the Modulation of Biomarkers in MGUS-WS#81
    Role: Principal Investigator
    UARK 2001-01     (MEHTA, PAULETTE)Feb 7, 2002 - Jan 31, 2004
    Berlex Laboratories, Inc.
    UARK 2001-01, A Phase II Trial of Single Agent Campath 1-H for the Treatment of Refractory or Relapsed CD52 + Multiple Myeloma
    Role: Principal Investigator
    UARK 2001-01 Amend. #1     (MEHTA, PAULETTE)Feb 7, 2002 - Jan 31, 2004
    Berlex Laboratories, Inc.
    UARK 2001-01, A Phase II Trial of Single Agent Campath 1-H for the Treatment of Refractory or Relapsed CD52 + Multiple Myeloma
    Role: Principal Investigator
    UARK 2001-01 Amend. #2     (MEHTA, PAULETTE)Feb 7, 2002 - Jan 31, 2004
    Berlex Laboratories, Inc.
    UARK 2001-01, A Phase II Trial of Single Agent Campath 1-H for the Treatment of Refractory or Relapsed CD52 + Multiple Myeloma
    Role: Principal Investigator

    Collapse Outreach 
    Collapse outreach overview
    Co-creator and co-sponsor of the "Paulette and Jay Mehta Creative Writing Award," 2021-indefinitely


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Arnold SD, Brazauskas R, He N, Li Y, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Hashmi S, Parsons S, Wood WA, Steinberg A, Freytes CO, Dandoy CE, Marks DI, Lazarus HM, Abdel-Azim H, Bitan M, Diaz MA, Olsson RF, Gergis U, Seber A, Wirk B, LeMaistre CF, Ustun C, Duncan C, Rizzieri D, Szwajcer D, Fagioli F, Frangoul H, Knight JM, Kamble RT, Mehta P, Schears R, Satwani P, Pulsipher MA, Aplenc R, Saber W. The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis. Biol Blood Marrow Transplant. 2020 09; 26(9):1747-1756. PMID: 32464284.
      View in: PubMed
    2. Mehta P, Mehta J. Reframing Clinician Distress: Moral Injury Not Burnout. Fed Pract. 2019 Nov; 36(11):504-506. PMID: 31892771.
      View in: PubMed
    3. Makhoul I, Motwani P, Schafer L, Arnaoutakis K, Mahmoud F, Safar M, Graves D, Mehta P, Govindarajan R, Hutchins L, Thrush C. Integrating Collaborative Learning and Competition in a Hematology/Oncology Training Program. J Cancer Educ. 2018 02; 33(1):186-192. PMID: 27516202.
      View in: PubMed
    4. Guru Murthy GS, Hamadani M, Bhatt VR, Dhakal I, Mehta P. Systemic Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma: A Population-based Analysis of Incidence and Survival. Clin Lymphoma Myeloma Leuk. 2017 04; 17(4):201-206. PMID: 28395812.
      View in: PubMed
    5. Bansal M, Abdallah AO, Pennisi A, Arnaoutakis K, Makhoul I, Mehta P. Improving Communication on Intent of Chemotherapy Using QOPI Scores and PDSA Cycles. J Cancer Educ. 2016 12; 31(4):736-741. PMID: 26411307.
      View in: PubMed
    6. Guru Murthy GS, Dhakal I, Mehta P. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. Leuk Lymphoma. 2017 07; 58(7):1648-1654. PMID: 27881041.
      View in: PubMed
    7. Guru Murthy GS, Dhakal I, Lee JY, Mehta P. Acute Leukemia of Ambiguous Lineage in Elderly Patients - Analysis of Survival Using Surveillance Epidemiology and End Results-Medicare Database. Clin Lymphoma Myeloma Leuk. 2017 02; 17(2):100-107. PMID: 27998706.
      View in: PubMed
    8. Kaur V, Haider S, Sasapu A, Mehta P, Arnaoutakis K, Makhoul I. Addressing Opioid-Associated Constipation Using Quality Oncology Practice Initiative Scores and Plan-Do-Study-Act Cycles. J Oncol Pract. 2017 01; 13(1):e91-e97. PMID: 28084881.
      View in: PubMed
    9. Kaur H, Xiang Z, Kunthur A, Mehta P. Castleman Disease. Fed Pract. 2015 Aug; 32(Suppl 7):41S-46S. PMID: 30766129.
      View in: PubMed
    10. Jewell S, Xiang Z, Kunthur A, Mehta P. Multiple Myeloma: Updates on Diagnosis and Management. Fed Pract. 2015 Aug; 32(Suppl 7):49S-56S. PMID: 30766130.
      View in: PubMed
    11. Kunthur A, Xiang Z, Kaur H, Jewell S, Mehta P. Updates on Cancer Survivorship Care Planning. Fed Pract. 2015 Aug; 32(Suppl 7):64S-69S. PMID: 30766131.
      View in: PubMed
    12. Xiang Z, Abdallah AO, Govindarajan R, Mehta P, Emanuel PD, Papenhausen P, Schichman SA. MYC amplification in multiple marker chromosomes and EZH2 microdeletion in a man with acute myeloid leukemia. Cancer Genet. 2015 Mar; 208(3):96-100. PMID: 25800664.
      View in: PubMed
    13. Guru Murthy GS, Venkitachalam R, Mehta P. Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database. Leuk Lymphoma. 2015; 56(8):2296-300. PMID: 25495170.
      View in: PubMed
    14. Girnius SK, Lee S, Kambhampati S, Rose MG, Mohiuddin A, Houranieh A, Zimelman A, Grady T, Mehta P, Behler C, Hayes TG, Efebera YA, Prabhala RH, Han A, Yellapragada SV, Klein CE, Roodman GD, Lichtenstein A, Munshi NC. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. Br J Haematol. 2015 Apr; 169(1):36-43. PMID: 25572917.
      View in: PubMed
    15. Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN. New cancers after autotransplantations for multiple myeloma. Biol Blood Marrow Transplant. 2015 Apr; 21(4):738-45. PMID: 25555448.
      View in: PubMed
    16. Kaur V, Mehta P, Johnsurd J, Govindarajan R. Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia. Blood. 2014 Nov 27; 124(23):3503-5. PMID: 25431479.
      View in: PubMed
    17. Xiang Z, Kaur V, Aburiziq IK, Mehta P, Emanuel P, Schichman SA. Natural history of chronic myelomonocytic leukemia: gene sequencing identifies multiple clonal molecular abnormalities associated with rapid progression to acute myeloid leukemia. Clin Case Rep. 2014 Dec; 2(6):265-70. PMID: 25548628.
      View in: PubMed
    18. Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML. Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2015 Jan; 21(1):151-8. PMID: 25316109.
      View in: PubMed
    19. Guru Murthy GS, Venkitachalam R, Mehta P. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S90-5. PMID: 25486963.
      View in: PubMed
    20. Mehta P, Mehta JL. Do we know why deaths from heart disease have declined? Am J Cardiol. 2014 Nov 15; 114(10):1627. PMID: 25242365.
      View in: PubMed
    21. Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre CF, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1819-27. PMID: 25064747.
      View in: PubMed
    22. Wood WA, Lee SJ, Brazauskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, Lemaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS. Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2014 Jun; 20(6):829-36. PMID: 24607554.
      View in: PubMed
    23. Mehta J, Mehta P. Turmeric for Long Life, Good Health, and Delicious Meals. Hematocardiology Publishing Co. 2013; 533 KB.
    24. Xiang Z, Mehta P. Eipidemiology and Clinical Aspects of Multiple Myeloma and its Precursor Syndromes. Fed Pract. 2013; 30(Suppl 5):38S-42S.
    25. Mehta P. Review of "Hematopathology". JAMA. 2012; 308(10):1042-1043.
    26. Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS. Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1776-84. PMID: 22863842.
      View in: PubMed
    27. Mehta P. Review of "ARUP Consult: The PHysician's Guide to Laboratory Test Selection and Interpretation". JAMA. 2012; 307(22):2436-2437.
    28. Mehta P. Review of "Diagnostic Pediatric Hematopathology". JAMA. 2012; 307(17):1867-1868.
    29. Mehta P. Review of "Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management". JAMA. 2012; 307(12):1319.
    30. Mehta P. Review of "Stem Cells and Cancer Stem Cells: Therapeutic Applications in Disease and Injury, Volume 2". JAMA. 2012; 307(10):1087.
    31. Greene P, Mehta P, Yeary KH, Bursac Z, Zhang J, Goldsmith G, Henry-Tillman R. Using population data to reduce disparities in colorectal cancer screening, Arkansas, 2006. Prev Chronic Dis. 2012; 9:E138. PMID: 22898236.
      View in: PubMed
    32. Torrence WA, Yeary KH, Stewart C, Mehta P, Duke K, Greer-Williams N, Guidry JJ, Erwin D, Greene P, Henry-Tillman RS. Evaluating coalition capacity to strengthen community-academic partnerships addressing cancer disparities. J Cancer Educ. 2011 Dec; 26(4):658-63. PMID: 21633920.
      View in: PubMed
    33. Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2012 Jun; 18(6):903-12. PMID: 22062801.
      View in: PubMed
    34. Mehta P. Review of "Management of Hematologic Malignancies". JAMA. 2011; 306(16):1806-1807.
    35. Mehta P, Haggstrom DA, Latini DM, Ballard EA, Moye J. Cancer Survivorship Care: Summarizing the 6 Tools for Success. Fed Pract. 2011 Sep 01; 28(Suppl 6):43S-49S. PMID: 25983533.
      View in: PubMed
    36. Mehta P. Review of "Adults Acute Lymphocytic Leukemia: Biology and Treatment". JAMA. 2011; 305(22):2353-2358.
    37. Mehta P. Introduction to updates in oncology 2011. Fed Practitioner. 2011; 28(suppl 6):1.
    38. Mehta P. Review of "The Emperor of All Maladies: A Biography of Cancer". JAMA. 2011; 305(22):2353-2358.
    39. Mehta P. Review of "Postgraduate Haematology". JAMA. 2011; 305(16):1713-1714.
    40. Yeary K, Flowers E, Ford G, Burroughs D, Burton J, Woods D, Stewart C, Mehta P, Greene P, Henry-Tillman R. Development of a community-based participatory colorectal cancer screening intervention to address disparities, Arkansas, 2008-2009. Prev Chronic Dis. 2011 Mar; 8(2):A47. PMID: 21324261.
      View in: PubMed
    41. Balamurugan A, Mehta P, Bates J, Mehta JL. Change in mortality from coronary heart disease and stroke in Arkansas (1979 to 2007). Am J Cardiol. 2011 Jan 15; 107(2):156-60. PMID: 21211595.
      View in: PubMed
    42. Yacoub A, Mehta P. Learn while you wait: An experience of a novel, interactive VHA e-Notebook education program for multiple myeloma. Blood 116:2010. 2011.
    43. Mehta P, Haggstrom DA, Latini DM, Ballard EA. Cancer survivorship care: Summarizing the 6 tools for success. Fed Practitioner. 2011; 28(suppl 6):43-48.
    44. Mahmoud F, Mehta P. Multiple myeloma: Update for the primary care physician. Fed Practitioner. 2011; 28(suppl 6):2-7.
    45. Mehta P. Review of "The Emperor of All Maladies: A Biography of Cancer". JAMA. 2011; 305(22):2357-2358.
    46. Raval G, Mehta P. TNF-a inhibitors: are they carcinogenic? Drug Healthc Patient Saf. 2010; 2:241-7. PMID: 21701636.
      View in: PubMed
    47. Mehta P. Review of "Hematopoietic Stem Cell Biology". JAMA. 2010; 304(18):2069.
    48. Kyei M, Lavelle E, Kyasa J, Safar M, Makhoul I, Mehta P. Triaging referrals as part of hematology/oncology fellowship training. J Cancer Educ. 2010 Sep; 25(3):437-41. PMID: 20339965.
      View in: PubMed
    49. Mehta P. Review of "Chasing Medical Miracles: The Promise and Perils of Clinical Trials". JAMA. 2010; 304(12):1388-1389.
    50. Mehta P. Review of "Color atlas of clinical hematology". JAMA. 2010; 304(4):473-474.
    51. Mehta JL, Bursac Z, Mehta P, Bansal D, Marsh J, Sukhija R, Sachdeva R. Racial Disparities in Prescriptions for Cardioprotective Drugs and Clinical Outcomes in Veterans Affairs Hospitals, an Equal Access Healthcare System. Am J Cardiol. 2010; 105(7):1019-23.
    52. Kang BY, Hu C, Ryu S, Khan JA, Biancolella M, Prayaga S, Seung KB, Novelli G, Mehta P, Mehta JL. Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice. Physiol Genomics. 2010 Jun; 42(1):42-54. PMID: 20332185.
      View in: PubMed
    53. Mehta P. Review of "Cancer Stem Cells". JAMA. 2010; 303(11):1098.
    54. Mehta JL, Bursac Z, Mehta P, Bansal D, Fink L, Marsh J, Sukhija R, Sachdeva R. Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals. Am J Cardiol. 2010 Apr 01; 105(7):1019-23. PMID: 20346324.
      View in: PubMed
    55. Mehta P. Review of "Atlas of Hematologic Neoplasms". JAMA. 2010; 303(6):564.
    56. Mehta P. Update in ITP. Plenary session of National meeting. 2010.
    57. Raval G, Mehta P. TNF-alpha inhibitors: Are they carcinogenic?. Drugs Healthcare Pat Safety. 2010; 2:241-7.
    58. Kunther A, Safar A, Kyasa MJ, Makhoul I, Harrington S, Mehta P. Addressing End-of-Life Care - When the Patient or Family Doesn't Want to Let Go. 2010; 27(5):34-36.
    59. Mehta P, Thompson R. Plenary session of HOPE Unit at CAVHS: An Update. National meeting, Association of VA Hematologists/Oncologists. 2010.
    60. Mehta P. Review of "Wintrobe's Clinical Hematology". JAMA. 2009; 302(22):2488-2493.
    61. Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2010 Mar; 16(3):395-402. PMID: 19922808.
      View in: PubMed
    62. Greene P, Mays G, Kim K, Hager B, Goldsmith G, Bursac Z, Carter D, Duke K, Mehta P, Tillman RH. Colorectal cancer screening in Arkansas: implications for cancer prevention in primary care. J Ark Med Soc. 2009 Sep; 106(3):66-8. PMID: 19947018.
      View in: PubMed
    63. Sibley A, Mehta P. Review of "Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies". JAMA. 2009; 302:330-331.
    64. Mehta P. Review of "Oski and Nathan’s Pediatric Oncology". JAMA. 2009; 301:2273.
    65. Balamurugan A, Im L, Reeve G, Mehta P, Bates JH. Incidence of female breast cancer in Arkansas: are we following the national trend? J Ark Med Soc. 2009 Jun; 105(12):283-4, 286. PMID: 19606641.
      View in: PubMed
    66. Mehta P. Review of "Hematopoietic Stem Cell Transplantation". JAMA. 2009; 301:1606-7.
    67. Sibley A, Mehta P. Renal cell carcinoma: Past, present and future. Fed Practitioner. 2009; 26:9ff.
    68. Divekar R, Mehta P. Hepatocellular carcinoma: The facts of the matter. Fed Practitioner. 2009; 26(suppl 1):2-3.
    69. Raval GG, Tancinco E, Raval P, Mehta P. Hepatocellular Carcinoma: Diagnosis and Staging. Fed Prac. 2009; 26(Suppl 1):9-14.
    70. Raval G, Gujja S, Mehta P, Reese AC, Whitson JM, Konety BR, Sibley A, Mirza M, Van Veldhuizen PJ, Haideri N, Keefe S, Atherton C. Managing Advanced Renal Cell Carcinoma. Fed. Pract. 2009; 26(Supplement 4):1-22.
    71. Raval G, Mehta P. Review of "Transfusion Microbiology". JAMA. 2009; 301:438-439.
    72. Divekar R, Mehta P, El-Serag HB, Raval GG, Tancino E, Raval P, Taddei T, Monto A, Kohlwes J. Managing Advanced Hepatocellular Carcinoma. Fed Prac. 2009; 26(Suppl 1):1-24B.
    73. Kyei M, Mehta P. Triaging Consults As a Component of A Hematology/Oncology Rotation, American Association for Cancer Education. accepted for merit award and presented at. 2009.
    74. Nair B, Safar A, Garrison W, Sherman A, Mehta P. Smoking cessation among patients in a cancer clinic: evaluation of a novel, motivational stop-smoking pocket calendar. J Cancer Educ. 2009; 24(3):210-1. PMID: 19526409.
      View in: PubMed
    75. Monto A, Kohlwes J, Raval GG, Mehta P, Et al. Multidisciplinary perspectives on management: a roundtable discussion. Fed Prac. 2009; 26(Suppl 1):20-24.
    76. Sibley A, Mehta P. Presentation, diagnosis and treatment of early-stage disease. Fed. Pract. 2009; 26(Supplement 4):9-15.
    77. Mehta P. Review of “Blood Disorders in the Elderly”. JAMA. 2008; 300(18):2184 - 2185.
    78. Mehta P. Review of Gulati G and Caro J editors, “Blood Cells: An Atlas of Morphology With Clinical Relevance.”. JAMA. 2008; 300:853 - 854.
    79. Mehta P, Henry-Tillman R. Guest Editorial: Colorectal cancer screening in the VA. Fed Pract. 2008.
    80. Mehta P. Is burnout a well recognized issue among oncologists?. 2008.
    81. Mehta P. Review of Freshney RI et al, editors, “Culture of Human Stem Cells”. JAMA. 2008; 299:2572.
    82. Mehta P. Review of Bilko NM et al, editors, “Stem Cells and Their Potential for Clinical Application.”. JAMA. 2008; 299:1724-5.
    83. Mehta P. Review of Sekeres MA et al, “Clinical Malignant Hematology”. JAMA. 2008; 299:460.
    84. Mehta P, Lyckholm L. Point/Counterpoint: Is burnout a well recognized issue among physicians?. HemOncToday. 2008; 6:11.
    85. Wang-Gillam A, Valentine J, Sherman AC, Mehta P. Experiences of Institutional Review Board (IRB) and Protocol Review and Monitoring Committee (PRMC) rotations in hematology/oncology training. J Cancer Educ. 2008; 23(2):71-3. PMID: 18569240.
      View in: PubMed
    86. Mehta P, Holtan SG. Knowing too much. J Cancer Educ. 2008; 23(2):133-4. PMID: 18569250.
      View in: PubMed
    87. Mehta P, Henry-Tillman R. Obesity-related cancer: an emerging need for more education. J Cancer Educ. 2008; 23(4):201-3. PMID: 19058065.
      View in: PubMed
    88. Mehta P, Henry-Tillman R. Obesity as an emerging need for cancer education. J Cancer Educ. 2008; 23:201-203.
    89. Mehta P. Cancer Survivorship. 2008.
    90. Kesheva-Prasad H, Hester DM, Mehta J, Mehta P. Ethics Forum: Informed Consent in Medical Oncology. Fed Prac. 2008; 25(7):26, 29-31, 35.
    91. Henry-Tillman R, Mehta P. Guest Editorial: Breaking Down Barriers to Colorectal Cancer Screening. Fed Prac. 2008; 25(7):14,16.
    92. Nair B, Raval G, Mehta P. TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature. Am J Hematol. 2007 Nov; 82(11):1022-4. PMID: 17654504.
      View in: PubMed
    93. Prasad HK, Kaushal V, Mehta P. Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: case report and review of literature. Am J Hematol. 2007 Sep; 82(9):855-7. PMID: 17570510.
      View in: PubMed
    94. Mehta P. He didn't have a chance. J Clin Oncol. 2007 Aug 01; 25(22):3378-9. PMID: 17664488.
      View in: PubMed
    95. Mehta P, Hester M, Safar AM, Thompson R. Ethics-in-oncology forums. J Cancer Educ. 2007; 22(3):159-64. PMID: 17760521.
      View in: PubMed
    96. Mehta P. Special treatment: Commentary on "When Two Worlds Collide". J Clin Oncol. 2007; 25:4015-4016.
    97. Kapoor P, Singh E, Radhakrishnan P, Mehta P. Splenectomy in plasma cell dyscrasias: a review of the clinical practice. Am J Hematol. 2006 Dec; 81(12):946-54. PMID: 16937390.
      View in: PubMed
    98. Midathada M, Mehta J, Govindarajan R, Safar AM, Hester DM, Kyasa MJ, Mehta P. When substance abuse interferes with cancer treatment. Federal Practitioner. 2006; 23(9):39-40, 42, 51.
    99. Sherman AC, Edwards D, Simonton S, Mehta P. Caregiver stress and burnout in an oncology unit. Palliat Support Care. 2006 Mar; 4(1):65-80. PMID: 16889325.
      View in: PubMed
    100. Joseph J, Rimawi A, Mehta P, Cottler-Fox M, Sinha A, Singh BK, Pacheco R, Smith ES, Mehta JL. Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure. Am J Cardiol. 2006 Mar 01; 97(5):681-4. PMID: 16490437.
      View in: PubMed
    101. Safar AM, O'Sullivan P, Ray L, Hutchins L, Mehta P. Editorial clubs as a new teaching tool in postgraduate training. J Cancer Educ. 2006; 21(3):163-5. PMID: 17371182.
      View in: PubMed
    102. Wang-Gillam A, Mehta P. IRB rotations to promote systems competency in hematology/oncology fellowship training programs. J Cancer Education, 21 suppl 2. 2006; 24.
    103. Norris LB, Mehta P. The role of granulocyte growth factors. Federal Practitioner. 2006; 23(supplement 2):16-25.
    104. Kaushal V, Mehta P, Fink L. Tissue factor and factor VIIa regulate expression of Ets-1 in prostate cancer. International Society for Thrombosis and Hemostasis. 2006.
    105. Kapoor P, Singh E, Radhakrishnan P, Mehta P. Splenectomy in plasma cell dyscrasias: a review of clinical practice. Am J Hematol. 2006; 81:945-54.
    106. Nair B, Mehta P. Pilot program of smoking cessation in patients with smoking-related cancers. J Cancer Education, 21 suppl 2. 2006; 40.
    107. Mehta P. Chemotherapy induced neutropenia in the new millennium. Federal Practitioner. 2006; 23(supplement 2):2-3.
    108. Raval GG, Wingard JR, Mehta P. Bone Marrow Transplantation, Long-Term Effects. 2006.
    109. Safar AM, Kyasa MJ, Thompson R, Hester M, Mehta P. Impact of ethics-in-oncology forums in a Hematology Oncology Fellowship Program. presented at. 2006.
    110. Carter G, Mehta P. Decreased erythropoietin usage in a VA center using a model outreach program. presented at. 2006.
    111. Mehta P, Kaushal V. Effect of daclizumab for graft-versus-host disease after bone marrow transplantation on lymphocyte-endothelial cell interaction. International Society for Thrombosis and Haemostasis. 2006.
    112. Gentry R, Mehta J, Hester M, Thompson R, Safar M, Kyasa MJ, Mehta P. Disclosing prognoses, when patients don't ask. Federal Practitioner. 2006; 23:14-33.
    113. Johnson LA, Alikan MA, Mehta P, Culp WC. Caval perforation with bronchial communication: a rare complication of long-term venous access. J Vasc Interv Radiol. 2005 Aug; 16(8):1149-52. PMID: 16105929.
      View in: PubMed
    114. Hayes E, Mehta P, Mehta JL. Depression in heart disease--a plea for help! Indian Heart J. 2005 Jul-Aug; 57(4):360-3. PMID: 16350688.
      View in: PubMed
    115. Khalil O, Govindarajan R, Safar M, Hutchins L, Mehta P. Clinical trial registration and the ICMJE. JAMA. 2005 Jan 12; 293(2):157; author reply 158. PMID: 15644532.
      View in: PubMed
    116. Kaushal V, Mehta P, Gokden N, Kohli M, Dennis RA, Fink LM. ETS-1 and tissue factor expression and regulation in PC-3 cells in vitro and in prostate cancer in vivo. AACR. 2005.
    117. Khalil O, Govindarajan R, Safar M, Hutchins L, Mehta P. Clinical Trial registration and the ICMJE. 2005.
    118. Mehta P. Where have all the textbooks gone?. J Cancer Ed. 2005; 20:52.
    119. Wang-Gillam A, Mehta J, Thompson R, Mehta P. When it's time to stop cancer treatment: helping patients prepare for death. Federal Practitioner. 2005; 14-23.
    120. Nagarajan A, Mehta J, Safar M, Thompson R, Mehta P. When patient, family and doctors disagree on treatment. Federal Practitioner. 2005; 15-18.
    121. Schichman SA, McClure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol. 2004 Nov; 77(3):291-5. PMID: 15495247.
      View in: PubMed
    122. Kaushal V, Kaushal GP, Mehta P. Differential toxicity of anthracyclines on cultured endothelial cells. Endothelium. 2004 Sep-Dec; 11(5-6):253-8. PMID: 15763945.
      View in: PubMed
    123. Adamkiewicz TV, Mehta PS, Boyer MW, Kedar A, Olson TA, Olson E, Chiang KY, Maurer D, Mogul MJ, Wingard JR, Yeager AM. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant. 2004; 34(5):405 - 411.
    124. Alikhan MA, Carter G, Mehta P. Topical GM-CSF hastens healing of leg ulcers in sickle cell disease. Am J Hematol. 2004 Jun; 76(2):192. PMID: 15164391.
      View in: PubMed
    125. Mehta P. Review of "JAMA: The Journal of the American Medical Association 2004 291". JAMA. 2004; 291(10).
    126. Mehta P. Pediatric stem cell transplantation. The scientific basis of pediatric bone marrow transplantation. 2004.
    127. Mehta P. Pediatric Stem Cell Transplantation. Jones and Bartlett Publishers. 2004.
    128. Kohli M, Zent C, Hutchins LF, Safar M, Dotson P, Mehta P. The academic hematology-oncology firm:a model for postgraduate cancer education. J Cancer Educ. 2004; 19(1):45-9. PMID: 15059755.
      View in: PubMed
    129. Midathada MV, Mehta P, Waner M, Fink LM. Recombinant factor VIIa in the treatment of bleeding. Am J Clin Pathol. 2004 Jan; 121(1):124-37. PMID: 14750250.
      View in: PubMed
    130. Cheema P, Mehta P. Pediatric Stem Cell Transplantation. Stem Cell Transplantation: Ethic Concerns. 2004; 91-97.
    131. Kaushal V, Kaushal GP, Mehta P. Differential effects of anthracyclines on endothelial cell integrity. 2003.
    132. Mehta P, Fetting J. Can you cure him, for the baby's sake? J Clin Oncol. 2003 Nov 01; 21(21):4064-5. PMID: 14581431.
      View in: PubMed
    133. Mehta P, Hussein M. Thalidomide as anti-inflammatory therapy for multiple myeloma. Leukemia. 2003; 17(11):2237 - 2238.
    134. Mehta P. Thalidomide and thrombosis. Clin Adv Hematol Oncol. 2003 Aug; 1(8):464-5. PMID: 16258433.
      View in: PubMed
    135. Kohli M, Khan MA, Mehta P, Hutchins L. Combined endocrine blockade in premenopausal breast cancer: a superior therapeutic option for adjuvant management? J Clin Oncol. 2003 Jun 15; 21(12):2445. PMID: 12805351.
      View in: PubMed
    136. Kohli M, Kaushal V, Mehta P. Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost. 2003 Jun; 29(3):301-8. PMID: 12888934.
      View in: PubMed
    137. Zangari M, Saghafifar F, Mehta P, Barlogie B, Fink L, Tricot G. The blood coagulation mechanism in multiple myeloma. Semin Thromb Hemost. 2003 Jun; 29(3):275-82. PMID: 12888931.
      View in: PubMed
    138. Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR. Access to stem cell transplantation: do women fare as well as men? Am J Hematol. 2003 Feb; 72(2):99-102. PMID: 12555212.
      View in: PubMed
    139. Kaushal V, Kohli M, Mehta P, Mehta JL. Potential anticancer effects of statins: fact or fiction? Endothelium. 2003; 10(1):49-58. PMID: 12699077.
      View in: PubMed
    140. Mehta P, Sherman AC, Simonton S, Latif U, Nieder M. Addressing quality of life in survivors of pediatric bone marrow transplantation: practice patterns across centers. Clin Ther. 2003; 25(suppl 4):D36-D38.
    141. Kaushal V, Kaushal GP, Kohli M, Mehta P. Statins - Fact or Fiction?. Endothelium. 2003; 10:49-68.
    142. Mehta P. Pediatric Stem Cell Transplantation. Drugs Commonly Used in Pediatric Stem Cell Transplantations. 2003; pp 257-269.
    143. Mehta P. Pediatric Stem Cell Transplantation. Graft Versus Host Disease After Stem Cell Transplantation in Children. 2003; pp 401-411.
    144. Challagundla S, Mehta P. Pediatric Stem Cell Transplantation. Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia. 2003; pp 209-215.
    145. Miller S, Sharda S, Rodrigue J, Mehta P. Thalidomide in chronic graft-versus-host disease after stem cell transplantation: effects on quality of life. Int J Hematol. 2002 Nov; 76(4):365-9. PMID: 12463602.
      View in: PubMed
    146. Mehta P. Aspirin in the prophylaxis of coronary artery disease. Curr Opin Cardiol. 2002 Sep; 17(5):552-8. PMID: 12357134.
      View in: PubMed
    147. Kaushal V, Kohli M, Zangari M, Fink L, Mehta P. Endothelial dysfunction in antiangiogenesis-associated thrombosis. J Clin Oncol. 2002 Jul 01; 20(13):3042; author reply 3042-3. PMID: 12089240.
      View in: PubMed
    148. Kohli, M, Kaushal, V, Mehta P, Spencer, HJ. Prospective controlled trial of circulating angiogenic markers in stable and hormone-escaping advanced prostate cancer. American Society for Clinical Oncology. 2002.
    149. Cheema, P, Erkaman, L, Mehta P, Coke, P. Impact of race on outcome of different treatment modalities in esophageal carcinoma. American Society for Clinical Oncology. 2002.
    150. Kota, M, Kaushal, V, Kohli, M, Dotson, P, Coke, P, Mehta P. Demographic and clinical features of multiple myeloma in US veterans. Proceedings of ASH. 2002.
    151. Kohli, M, Kaushal, V, Spencer, HJ, Mehta P. Angiogenesis and Coagulation Pathway Interactions in Advanced Prostate Cancer. Proceedings of ASH. 2002.
    152. Mehta P, Vinson, L, Kohli, M, Safar, M, Zent, C, Hutchins, L. Barriers to registration of patients at Veterans Healthcare System hospitals to national cancer protocols. National meeting of the Veterans Healthcare System. 2002.
    153. Sharda S, Miller S, Rodrique J, Mehta P. Thalidomid and quality of life. Int J Hematology. 2002; 76:365-369.
    154. Kaushal, V, Kaushal, GP, Anaissie, EJ, Kuylo, P, Kohli, M, Fink, LM, Mehta P. Thalidomide-induced coagulopathy: evidence for an indirect effect on endothelium. Proceedings of ASH. 2002.
    155. Mehta P. Stem Cell Transplantation in the Young. JB Publishing Co. 2002.
    156. Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, Khan SA, Finiewicz KJ, Nguyen H, Clancy CJ, Mehta PS, Wingard JR. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 2002; 29(1):15 - 19.
    157. Kohli, M, Zent, C, Safar, M, Mehta P. PSA testing in a veterans population. National meeting of the Veterans Healthcare System. 2002.
    158. Sharda S, Carter J, Wingard JR, Mehta P. Monitoring vital signs in a bone marrow transplant unit: are they needed in the middle of the night?. Bone Marrow Transplant. 2001; 27(11):1197 - 1200.
    159. Skoda-Smith S, Douglas VK, Mehta P, Graham-Pole J, Wingard JR. Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. Bone Marrow Transplant. 2001; 27(3):329 - 332.
    160. Wilms, J, Marcus, R, Scarborough, M, Carroll, RR, Graham-Pole, J, Mendenhall, NP, Wingard, JR, Mehta P. Results of an ablative dose-stem cell rescue protocol for patients with non-metastatic Ewing's sarcoma: Results of 12-years of transplantation at the University of Florida. 42nd American Society of Hematology (ASH) Annual Meeting. 2001.
    161. Yeager, AM, Mehta P, Adamkiewicz, TV, Olson, E, Hsu, LL, Kedar, A, Olson, TA, Boyer, MW, Ogden, AK, Wingard, JR, Eckman, JR. Unrelated placental/umbilical cord blood cell (UCBC) transplantation in children with high risk sickle cell disease (SCD). 42nd American Society of Hematology (ASH) Annual Meeting. 2001.
    162. Mehta P. Status of molecular diagnosis of minimal residual disease detection. International Journal of Pediatric Hematology Oncology. 2001; 72:1-10.
    163. Reddy, V, Pollock, B, Sharda, S, Hopkins, J, Weeks, F, Manion, K, Roque, D, Leather, H, Finewicz, K, Khan, S, Mehta P, Moreb, J, Wingard, JR. GVHD and CMV antigenemia after allogenic peripheral blood stem cell transplantation: Comparison between myeloablative and non-myeloablative (MINI) conditioning regimens. 42nd American Society of Hematology (ASH) Annual Meeting. 2001.
    164. Taeb, P, Sharda, S, Marcus, R, Scargorough, M, Wingard, JR, Pollock, B, Mehta P. Results of an ablative dose-stem cell rescue protocol for patients with non-metastatic Ewing's sarcoma, metatstatic at diagnosis: Results of a 20 year experience at the University of Florida. 42nd American Society of Hematology (ASH) Annual Meeting. 2001.
    165. Mehta P, Mageed A, Robert C, Fisk D, Skoda-Smith S, Braylan R, Wingard JR. Donor leukocyte fusions after bone marrow transplantation in children: series from a single institution and review of the literature. Int J Pediatr Hematol Oncol. 2001; 72:71-79.
    166. Reddy V, Moreb J, Mehta P. Donor lymphocyte infusions for CML: possible effects of age and mobilization. Blood. 2000; 95(9):2994 - 2995.
    167. Mehta P, Rodriguez J, Nejame C, Gaa R, Wingard JR. Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant center. Bone Marrow Transplant. 2000; 25(6):673 - 676.
    168. Narwani, R, Reddy, V, Wingard, JR, Mehta P. Topical tacromlimus may be useful for skin manifestations of acute and chronic graft-versus-host disease (GVHD) after bone marrow transplantation (BMT). American Society of Hematology Annual Meeting. 2000.
    169. Mehta P, Marcus, R, Scarborough, M, Kedar, A, Graham-Pole, J, Wingard, JR. Update on Ewing's Sarcoma protocols and rationale for future therapies. Florida Association for Pediatric Tumor Programs Annual Meeting. 2000.
    170. Miller, SM, Sharda, S, Meyers, C, Taylor, K, Rodrique, J, Wingard, JR, Mehta, P. Quality of Life (QOL) of patients with chronic graft-vs-host disease (CGVHD): Effects of Thalidomide. American Society for Blood and Marrow Transplantation (ASBMT) meeting. 2000.
    171. Sharda, S, Carter, J, Wingard, JR, Mehta P. Vital signs in the bone marrow transplant unit (BMTU): Are they needed in the middle of the night?. American Society for Blood and Marrow Transplantation (ASBMT) meeting. 2000.
    172. Mehta P. Ambulatory Pediatrics. Transient erythroblastopenia of childhood in Stockman. 2000.
    173. Mehta P, Wingard J. Ambulatory Pediatrics. Care of the child after bone marrow transplantation. 2000.
    174. Sharda, S, Carter, J, Wingard, JR, Mehta P. Vital signs in the bone marrow transplant unit (BMTU): Are they needed in the middle of the night?. Florida Association for Pediatric Tumor Programs Annual Meeting. 2000.
    175. Miller, SM, Sharda, S, Sola, M, Reddy, V, Wingard, JR, Mehta P. Urinary Tumor necrosis factor a (TNFa) levels in patients undergoing bone marrow transplantation: Are they more useful than serum levels?. American Society for Blood and Marrow Transplantation (ASBMT) meeting. 2000.
    176. Narwani, R, Wingard, JR, Mehta P. Predictive value of ATGAM skin testing and recommendations for interpretation. American Society of Hematology Annual Meeting. 2000.
    177. Narwani, R, Reddy, V, Gross, MA, Coons, M, Hopkins, JC, Wingard, JR, Mehta P. Predisposing factors for catheter infections in bone marrow transplant (BMT) patients. American Society of Hematology Annual Meeting. 2000.
    178. Grow, WB, Moreb, JS, Roque, D, Manion, K, Leather, H, Reddy, V, Khan, SA, Mehta P, Wingard, JR. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. American Society of Hematology Annual Meeting. 2000.
    179. Khan, SA, Hopkins, J, Peracha, SM, Reddy, V, Mehta P, Skoda-Smith, S, Moreb, JS, Wingard, JR. Delayed lymphocyte recovery after bone marrow transplant is associated with increased likelihood of bacterial and fungal infections and poor survival. American Society of Hematology Annual Meeting. 2000.
    180. Miller, SM, Sharda, S, Sola, M, Reddy, V, Wingard, JR, Mehta P. Urinary Tumor necrosis factor a (TNFa) levels in patients undergoing bone marrow transplantation: Are they more useful than serum levels?. Florida Association for Pediatric Tumor Programs Annual Meeting. 2000.
    181. Mehta P, Beltz S, Kedar A, Graham-Pole J, Wingard JR. Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation. Bone Marrow Transplant. 1999; 24(12):1323 - 1327.
    182. Sullivan KJ, Goodwin SR, Evangelist J, Moore RD, Mehta P. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med. 1999; 27(11):2563 - 2568.
    183. Mehta P, Wingard JR. Musculoskeletal tumors of childhood. N Engl J Med. 1999; 341(22):1702 - 1703.
    184. Reddy V, Khan S, Wingard JR, Mehta P. Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations. Blood. 1999; 94(5):1833 - 1834.
    185. Tebes CC, Mehta P, Calhoun DA, Richards DS. Congenital ischemic forearm necrosis associated with a compound presentation. J Matern Fetal Med. 1999; 8(5):231 - 233.
    186. Mehta P, Kedar A, Graham-Pole J, Skoda-Smith S, Wingard JR. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature. Pediatrics. 1999; 103(4):e44 - .
    187. Mehta P, Graham-Pole, J, Kedar, A, Skoda-Smith, S, Weeks, F, Moreb, J, Khan, S, Peracha, S, Wingard, JR. Adoptive immunotherapy in children compared to adults. Annual meeting of the American Pediatric Society/Society for Pediatric Research. 1999.
    188. Mehta P, Wingard J. Pediatrics Emergency Textbook. Long-term complications after bone marrow transplantation. 1999.
    189. Khan, S, Hopkins, J, Peracha, S, Weeks, R, Reddy, V, Mehta, P, Moreb, J, Skoda-Smith, S, Wingard, JR. Delayed lymphocyte recovery after bone marrow transplant is associated with increased likelihood of bacterial and fungal infections and poor survival. 1999 Tandem Bone Marrow Transplant Meeting. 1999.
    190. Sullivan K, Salvatore G, Evangelist J, Moore R, Mehta P. Inhaled nitric oxide successfully used to treat acute chest syndrome in a young adolescent with sickle cell disease. Critical Care Medicine. 1999; 27:2563-8.
    191. Yarrington A, Mehta P. Does sleep promote recovery after bone marrow transplantation?--A hypothesis. Pediatr Transplant. 1998; 2(1):51 - 55.
    192. Kubilium, N., Noel, T, Gruen, W, Wingard, JR, Mehta P. Actigraphy as measure of sleep in patients undergoing bone marrow transplantation (BMT) and in their physicians. 1998; 333b.
    193. Slayton W, Abdel-Mageed A, Kabanni M, Kays D, Mehta P. Clostridium septicum myonecrosis in a child with aplastic anemia treated successfully with conventional therapy and bone marrow transplantation. International Journal of Pediatric Hematology Oncology. 1998; 6:85-88.
    194. Mehta P, Beltz S, Cousins D. A review of the national chemotherapy errors and recommendations for safe administration. International Journal of Pediatric Hematology Oncology. 1998; 5:463-473.
    195. Sopkowiak, T, Gaa, B, Nejame, C, Boyete, R, Rodrique, J, Mehta P. Decision making in a transplant unit. 3rd Annual Conference of Women's Health. 1998.
    196. Beltz, S, Mehta P, Wingard, JR. Pharmacokinetics of tacrolimus in children undergoing bone marrow transplantation. American Society of Hematology Annual Meeting. 1998; 130a.
    197. Kubiliun, N, Noel, T, Dame, J, Wingard, J.R., Mehta P. Urine and serum cytokines in patients undergoing bone marrow (BMT) and peripheral blood stem cell transplants (PBSCT). 1998; 333b.
    198. Noel, T, Kubilium, N, Allen, S, Wingard, J.R., Mehta P. Melatonin production is decreased in patients admitted to a bone marrow transplant unit (BMTU) but diural cycle is maintained. 1998; 336b.
    199. Friedman T, Slayton WB, Allen LS, Pollock BH, Dumont-Driscoll M, Mehta P, Graham-Pole J. Use of alternative therapies for children with cancer. Pediatrics. 1997; 100(6):E1 - .
    200. Yang BC, Mehta P, Mehta JL. Nitric Oxide Synthesis Inhibition and Role of P-selectin in Leukocyte Adhesion to Vascular Tissues. J Cardiovasc Pharmacol Ther. 1997; 2(2):107 - 114.
    201. Sabbagh, R, Mehta P. Monocyte-platelet conjugates are increased in patients with sickle cell disease. The American Society of Pediatric Hematology/Oncology. 1997.
    202. Yang BC, Strates B, Mehta P, Mehta J. Cardioprotective effects of platelets against ischemia-reperfusion injury are mediated via release of transforming growth factor-B1. 1997.
    203. Mehta P, Wingard, J.R. Thalidomide is not effective for acute graft-versus-host disease. 1997; 372b.
    204. Abdel-Mageed, A., Del Rosario, M, Hutcheson, C, Gian, V, Mehta P, Kedar, A, Graham-Pole, J, Moreb, J, Fisk, D, Sugrue, M, Roberts, C, Wingard, J.R. Unrelated umbilical cord blood transplantation in children and adults with high risk hematologic malignancies. 1997; 392b.
    205. Allen, S, Mehta P. Sleep problems in bone marrow transplant recipients: Potential relevance to melatonin dysregulation. American Society of Hematology. 1997; 224a.
    206. Mehta P, Bentrup KL. Women and HIV infection. J Fla Med Assoc. 1996; 83(7):473 - 478.
    207. Mehta P. Hematology: A Problem Oriented Approach. Investigation and management of platelet abnormalities. 1996; pp 553-567.
    208. Yarrington, A, Slayton, B, Mehta P. To Sleep, Perchance to Dream: Nighttime in the Bone Marrow Transplant Unit. Pediatric Science Day. 1996.
    209. Mehta P. Book review of "Sickle Cell Disease: basic principles and clinical practice". N England J Med. 1995.
    210. Mehta P, Bryant J, Mehta J. Oxidized LDL decreases nitric oxide synthase activity in human neutrophils. Reversal of the effects of oxidized-LDL by HDL and Larginine. Biochemical Pharmacology. 1995; 50:1181-1185.
    211. Kumar M, Mehta P. Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman. Am J Hematol. 1994; 46(3):241 - 244.
    212. Mehta P, Gross S, Kao KJ. A Practical Guide to Pediatric Intensive Care. Platelet Transfusions. 1994; pp 1008-1009.
    213. Mehta P, Kao KJ, Gross S. A Practical Guide to Pediatric Inensive Care. Transfusions with packed red blood cells. 1994; pp 101-107.
    214. Mehta P, Gross S, Kao KJ. A Practical Guide to Pediatric Intensive Care. Granulocyte transfusions. 1994; pp 1010-1011.
    215. Mehta P. Coagulation and platelet abnormalities in patients with cancer. J Pediatr hematol/Oncol. 1994; 1:73-85.
    216. Mehta P. Neoplastic Diseases of Childhood. Mechanisms of tumor metastasis. 1994; p 51-62.
    217. Mohammed SS, Christopher MM, Mehta P, Kedar A, Gross S, Derendorf H. Increased erythrocyte and protein binding of codeine in patients with sickle cell disease. J Pharm Sci. 1993; 82(11):1112 - 1117.
    218. Mohammed SS, Ayass M, Mehta P, Kedar A, Gross S, Derendorf H. Codeine disposition in sickle cell patients compared with healthy volunteers. J Clin Pharmacol. 1993; 33(9):811 - 815.
    219. Ayass M, Bussing R, Mehta P. Munchausen syndrome presenting as hemophilia: a convenient and economical 'steal' of disease and treatment. Pediatr Hematol Oncol. 1993; 10(3):241 - 244.
    220. Puri S, Mehta P, Donnelly W, Cumming W. An abdominal mass with surprising findings. Am J Pediatr Hematol Oncol. 1993; 15(2):262 - 267.
    221. Mehta P, Bussing R. Factitious coagulopathy due to Munchausen syndrome by proxy. Am J Pediatr Hematol Oncol. 1993; 15(1):124 - 125.
    222. Mohammed S, Christopher M, Mehta P, Kedar A, Gross S, Derendorf H. Erythrocyte and protein binding of codeine in sickle cell patients compared to healthy controls. J Pharmacol Sci. 1993; 82:1112-1117.
    223. Mehta P, Mehta J. Cardiovascular Pharmacology and Therapeutics. Anticoagulants. 1993; pp 281-298.
    224. Mehta P, Saba H, Et. al. Emergency Room Care for Hemophiliacs: Understanding and overcoming difficulties. J Fl Med Assoc. 1993; 4:250-254.
    225. Bryant, J, Yang, Bai Chun, Mehta P, Saldeen, T, Mehta, J. Dietary fish oil decreases superoxide radical generation without affecting nitric oxide synthase activity: A mechanism of vasorelaxation. American College of Cardiology 42nd Annual Scientific Session. 1993.
    226. Vats T, Buchanan G, Mehta P, Ragab A, Hvizdale E, Nitschke R, Link M, Beardsley GP, Maybee D, Krischer J. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. Invest New Drugs. 1992; 10(3):231 - 234.
    227. Nicolini, F.A., Lopez, L.M., Von der Porten, A.E., Wilcox, C., Mehta P, Et al. Dissociation between serum thromboxane A2 and ADP-induced platelet aggregation after daily intake of 325mg aspirin. 1992.
    228. Vaddi, K, Nicolini, F.A., Mehta P, Mehta, J.L. Increased tumor necrosis factor alpha and interferon gamma secretion by mononuclear leukocytes in ischemic heart disease. 1992; 240A.
    229. Bussing, R, Mehta P. Prevalence of anxiety disorders and self reported intra-family stress in HIV infected children with hemophilia. Florida HIV conference. 1992.
    230. Mehta P, Saba H, Lian E, Davis J, Cumming W, Barrett D, Sandler E, Kalen V, Kao KJ, Reiter W, . Guidelines for hemophilia care. J Fla Med Assoc. 1991; 78(4):222 - 224.
    231. Mehta P, Sandler E, Bussing R, Cumming W, Bedell W, Warner R, Levine SB. Reflections on hemophilia camp. Clin Pediatr (Phila). 1991; 30(4):259 - 260.
    232. Mehta P. Book review: Hematological Aspects of Systemic Diseases. N Engl J Med. 1991; 324:1602.
    233. Mehta P, Nicolini, F.A., Mehta, J.L. Influence of extracellular calcium on superoxide radical generation in cholesterol poor or cholesterol rich neutrophils. Effects of slow calcium blockers. 1991; 459A.
    234. Lawson, D.L., Yang, B.C., Mehta P, Mehta, J.L. Sustained anoxia decreases vascular contraction and endothelium dependent and independent vascular relaxation. 1991; II-654.
    235. Lawson, D.L., Mehta P, Mehta, J.L. Vasoconstrictor and vasorelaxant effects of endothelin 1 on rat aorta. 1991; 262A.
    236. Mehta P, Burton K, Sarkis E, Kemph J, Hill S, Bright C. Depression in children with hemophilia. J Fl Med Assoc. 1991; 9:572-576.
    237. Mehta P, Kimura A, Lawson D. Effects of calcium channel-blocking agents on platelet-osteogenic sarcoma interaction: platelet aggregation and electron microscopic findings. J Orthop Res. 1990; 8(5):629 - 634.
    238. Saleh R, Graham-Pole J, Cassano W, Abbot F, Vander Griend R, Dickson N, Mehta P, Heare M, Kedar A, Heare T, Gross S. Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy. Cancer. 1990; 65:861-865.
    239. Mehta P. AIDS in patients with hemophilia: Medical and psychosocial factors. Pediatr Reviews Communications. 1990; 4:127-135.
    240. Grana N, Fort J, Bright C, Mehta P. Subcutaneous DDAVP for patients with bleeding disorders`. Hematol Rev. 1990; 4:167-171.
    241. Mehta P, Lawson D, Gross S, Graham-Pole J. Comparative effects of mezlocillin and carbenicillin on platelet function and thromboxane generation in patients with cancer. Am J Pediatr Hematol Oncol. 1989; 11(3):286 - 291.
    242. Mehta P, Lawson D, Garrido R, Mehta J. Inhibition by streoptokinase of human platelet aggregation and thromboxane A2 generation and neutrophil chemotaxis. J Vascul Med biology. 1989; 1:227-233.
    243. Mehta P, Lawson D, Ward MB, Kimura A, Gee A. Effect of human tumor cells on platelet aggregation: potential relevance to pattern of metastasis. Cancer Res. 1987; 47(12):3115 - 3117.
    244. Kimura AK, Mehta P, Xiang JH, Lawson D, Dugger D, Kao KJ, Lee-Ambrose L. The lack of correlation between experimental metastatic potential and platelet aggregating activity of B16 melanoma clones viewed in relation to tumor cell heterogeneity. Clin Exp Metastasis. 1987; 5(2):125 - 133.
    245. Mehta P, Mehta, J., Ward, M.B., Lawson, D. Modification of platelet neutrophil interaction by selective thromboxane (TXA2) synthetase inhibitor U63, 557A. 1987; 601.
    246. Mehta, J., Lawson, D, Mehta P, Nichols, W.W. Leukotriene-induced relaxation of pre-contracted rat aortic rings: dependence on endothelial integrity. American Society for Clinical Investigation. 1987; 573.
    247. Mehta P, Lawson D, Ward MB, Lee-Ambrose L, Kimura A. Effects of thromboxane A2 inhibition on osteogenic sarcoma cell-induced platelet aggregation. Cancer Res. 1986; 46(10):5061 - 5063.
    248. Mehta P, Gross S, Graham-Pole J, Gardner R. Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children. J Pediatr. 1986; 108(5 Pt 1):774 - 776.
    249. Mehta P, Kimura, A, Lawson, D. Osteogenic sarcoma (MG-63)-induced platelet activation: Modulation by thromboxane inhibitors. Soc Pediatr Res. 1986; 283.
    250. Mehta, J, Mehta P, Ostrowski, N. Reduced platelet affinity for epinephrine in acute myocardial infarction. 1986; 181-192.
    251. Lawson, D, Mehta, J., Mehta P. Synergism between quinidine and aspirin on reduction in alpha2-adrenoreceptor affinity. American Heart Association 58th Annual Scientific Sessions. 1986; 194.
    252. Mehta P, Kimura, A, Lawson, D, Gee, A. Human osteogenic sarcoma cells stimulate platelet aggregation but leukemia and lymphoid cells do not. Clin Res, 34. 1986; 226A.
    253. Mehta P, Kimura, A, Lawson, D, Xiang, J, Dugger, D. Platelet aggregating activity of B16 melanoma cells does not correlate with metastatic potential. Clin Res, 34. 1986; 226A.
    254. Krop, I, Mehta, J.L., Mehta P, Lawson, D. Epinephrine-induces primary wave of platelet aggregation: An index of alpha2-adrenoreceptor activity. Southen Society for Clinical Investigation. 1986; 178A.
    255. Mehta J, Mehta P, Ostrowski N. Reduced platelet affinity for epinephrine in acute myocardial infarction. J Applied Cardiol. 1986; 1:181-192.
    256. Mehta, J, Mehta P, Bissell, C., Lawson, D. Alteration in platelet alpha2-adrenoreceptors by aspirin. 1985.
    257. Harris, K, Mehta P, Kumura, A, Gee, A. Platelet-tumor cell interaction in relation to route of metastatic spread of tumor cell lines. 1985.
    258. Mehta P. Pediatric Hematology/Oncology Reviews. Platelet-vessel wall interaction: Implications in childhood diseases. 1985; pp 52-70.
    259. Mehta P, Mehta, J. Effect on aspirin on alpha2-receptors on human platelets. 1985; 265A.
    260. Mehta P, Gross S, Ostrowski N. Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. Am J Pediatr Hematol Oncol. 1985; 7(1):88 - 91.
    261. Mehta P. Platelet and vessel wall prostaglandins in sickle cell disease. Eur Paediatr Haematol Oncol. 1985; 2:61-66.
    262. Mehta P, Ostrowski N, Brigmon L. Decreased stabilization of prostacyclin activity in patients with bone tumors. Cancer Res. 1984; 44(7):3132 - 3134.
    263. Kekomaki R, Elfenbein G, Gardner R, Graham-Pole J, Mehta P, Gross S. Improved response of patients refractory to random-donor platelet transfusions by intravenous gamma globulin. Am J Med. 1984; 76(3A):199 - 203.
    264. Mehta P, Mehta, J., Aguila, E., Ostrowski, N. Inhibition of platelet activation by very low concentrations of prostacyclin. 1984; 315A.
    265. Mehta P. Hemostatic Mechanisms and Metastasis. Evidence for abnormalities in arachidonic acid metabolism in tumor metastasis. 1984; pp 232-243.
    266. Mehta P, Gee, A., Kimura, A. Platelet-tumor cell interaction in relation to route of metastatic spread of tumors. 1984; 249A.
    267. Mehta P, Mehta JL. The aspirin dilemma revisited. NEJM. 1984; 310:1326-7.
    268. Mehta P, Mehta JL. New England Journal of Medicine. The aspirin dilemma revisited. 1984; 310:1326-1327.
    269. Mehta P. Prostaglandins and tumor metastasis. Eur Paediatr haematol Oncol. 1984; 1:1-5.
    270. Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood. 1984; 63(1):55 - 63.
    271. Mehta P, Springfield D, Ostrowski N. Arterial prostacyclin generation is decreased in patients with malignant bone tumors. Cancer. 1983; 52(7):1297 - 1300.
    272. Behnke M, Nackashi JA, Raulerson MD, Schuler PM, Mehta P. Childhood and Death. The pediatrician and the dying child. 1983; pp 69-93.
    273. Mehta J, Mehta P, Ostrowski N, Brigmon L. Calcium blocker diltiazem inhibits human platelet TXA2 synthesis and increase vessel wall PGI2 release. 1983; 251A.
    274. Mehta P, Albiol L. Prostacyclin and platelet aggregation in sickle cell disease. Pediatrics. 1982; 70(3):354 - 359.
    275. Mehta J, Mehta P. Review of "Platelets and Prostaglandins in Cardiovascular Disease". JAMA. 1982; 247(20):2835.
    276. Setzer ES, Webb IB, Wassenaar JW, Reeder JD, Mehta PS, Eitzman DV. Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant. J Pediatr. 1982; 100(4):599 - 605.
    277. Mehta P, Mehta, J., Roy, L., Ostrowski, N. Effects of nafazatrom on platelet TXA2 generation and PGI2 degradation. 1982; 839A.
    278. Mehta P, Mehta, J., Ostrowski, N., Brigmon, L. Ionophore A23187 potentiates ADP-induced platelet aggregation and thrmoboxane A2 generation. 1982; 872A.
    279. Mehta P, Springfield D, Spanier S, Ostrowski N. Arterial prostacyclin generation is decreased in patients with malignant tumors. 1982; 878A.
    280. Mehta P, Mehta, J., Crews, F., Roberts, A., Ostrowski, N. Human vascular tissues produce thromboxane A2 as well as PGI2. 1982; II-59.
    281. Mehta JL, Mehta P. The role of platelets and prostaglandins in coronary artery disease. L'Information Cardiologique. 1982; 6:261-278.
    282. Mehta P, Mehta, J. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostacyclin generation. 1982; 941.
    283. Mehta, J., Nichols, W., Mehta P, Conti, C.R. Thromboxane and prostacyclin in systemic and coronary vascular beds following endoperoxide analog infusion. 1982; 1014.
    284. Roberts, A.J., Mehta, J., Hay, D.A., Roy, L., Knauf, D., Alexander, J., Mehta, P. Effects of papaverine on human saphenous vein graft preparation during coronary sugery. 1982; II-134.
    285. Mehta, J., Mehta P, Feldman, R., Conti, C.R. Influence of tachycardia stress and nitroglycerin on thromboxane levels in coronary disease. 1982; 902.
    286. Mehta JL, Mehta P, Roy L, Abela GS, Conti CR. L'Information Cardiologique. The role of platelets and prostaglandins in coronary artery disease. 1982; 6:261-278.
    287. Mehta, J., Mehta P, Feldman, R.L., Conti, C.R. Modulation of vasoactive prostaglandins by nitroglycerin. 1982; II-178.
    288. Mehta, J., Nichols, W.W., Mehta, P. Influence of endoperoxide analog U46619, on coronary and sytemic hemodynamics. 1981; 274A.
    289. Mehta P, Mehta J. Thromboxane and prostacyclin in sickle cell disease. 1981; 885A.
    290. Mehta P, Mehta J. Prostacylin and thromboxane release following mechanical trauma to human vessels. 1981; 236A.
    291. Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Platelet Function in hypertension. 1981; pp 285-288.
    292. Mehta P, Mehta J., Horalek, C. Dipyridamole inhibits thromboxane generation and promotes prostacyclin release. 1981; 11-292, 1854.
    293. Mehta J, Mehta P. The Effect of Platelet Active Drugs on the cardiovascular system. Influence of aspirin and dipyridamole on platelet-endothelial interactions: Implications in coronary artery disease. 1981; pp 175-192.
    294. Setzer, E.S., Webb, I, Wassenaar, J.W., Reeder, J.D., Mehta, P., Eitzman, D.V. Platelet dysfunction: An etiologic factor in intraventricular hemorrhage (IVH) in the premature. 1981; 1423.
    295. Mehta P, Mehta, J. Influence of nicotine on platelets and vessel wall prostaglandins. 1981; 814A.
    296. Mehta P, Mehta, J, Roberts, A. Synthesis of thromboxane A2 and prostacyclin by newborn and adult human vascular tissue. 1981; 863A.
    297. Mehta, J., Nichols, W., Mehta P, Conti, C.R. Thromboxane and prostacyclin in systemic and coronary vascular beds following endoperoxide analog infusion. 1981; 855A.
    298. Mehta P, Mehta J. Platelets and Prostaglandin in Cardiovascular Disease. Platelet function in sickle cell disease. 1981; pp 435-438.
    299. Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Effects of smoking and nicotine on platelet-endothelial cell activity. 1981; pp 289-94.
    300. Mehta, J., Mehta, P., Zipper, R., Horalek, C. Thromboxane/prostacyclin equilibrium at rest and during exercise in man, and its relationship to myocardial ischemia. 1981; 223A.
    301. Bishopric N, Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Platelet activation and platelet suppresive drugs. 1981; pp 71-90.
    302. Miller RR, Mehta JL, Kumpuris AG, Mehta P, Luchi RJ. Platelets and Prostaglandins in Cardiovascular Disease. Platelet activation during exercise in coronary artery disease. 1981; pp 331-334.
    303. Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Platelet function in diabetes mellitus. 1981; pp 279-84.
    304. Mehta J, Mehta P. Platelets and Prostaglandins in Cardiovascular Disease. Platelet function in diabetes mellitus. 1981; pp 279-84.
    305. Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Evaluation of platelet function. 1981; pp 37-54.
    306. Mehta P, Mehta JL. Platelets and Prostaglandin in Cardiovascular disease. Platelet function in cerebrovascular ischemia. 1981; pp 429-434.
    307. Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Role of platelet and endothelium in vascular disease. 1981; 1.
    308. Mehta JL, Mehta P. Platelets and Prostaglandins in Cardiovascular disease. Congestive heart failure, vasodilator agents and platelet function. 1981; pp 369-385.
    309. Mehta P, Mehta JL. Platelets and Prostaglandins in Cardiovascular Disease. Platelet function across the human myocardial vasular bed. 1981; pp 315-330.
    310. Mehta P. Increased plasma thromboxane levels in sickle cell disease. 1981; 837.
    311. Mehta JL, Mehta P. Platelets and Prostaglandins in Cardiovascular Disease. Myocardial ischemia in man: Abnormal platelet aggregation and prostaglandin generation. 1981; pp 369-385.
    312. Mehta P. Significance of plasma beta-thromboglobulin values in patients with sickle cell disease. J Pediatr. 1980; 97(6):941 - 944.
    313. Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr. 1980; 97(5):791 - 794.
    314. Mehta P, Mehta J. Heparin potentiates platelet aggregation induced by cyclic endoperoxide analogue. 1980; III-192.
    315. Mehta, J., Mehta, P. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacycliln and thromboxane A2 in angina pectoris. 1980; 454.
    316. Setzer, E.S., Webb, I., Mehta P., Kane, J., Rossley, K.A., Eitzman, D.V. Relationship of birthweight and postnatal age to platelet function in neonates. 1980; 540.
    317. Mehta, J., Mehta P, Conti, C. Dipyridamole decreases platelet adhesion in atherosclerotic coronary arteries and potentiates prostacyclin in vitro. 1980; III-309.
    318. Mehta P, Carroll, R.G., Mehta, J., Gamble, D. Indium(III) labeled platelets for evaluation of in vitro platelet-endothelial interaction. 1980; 811A.
    319. Mehta, J., Mehta P, Miale, T. Increased platelet aggregate formation in congestive heart failure and its inhibition by nitroprusside. 1979; 428.
    320. Mehta P, Setzer, E., Zaytoun, A., Rossley, K., Mulet, M., Smith, B. Platelet activation as possible mechanism in the closure of the human umbilical cord. 1979; 252A.
    321. Mehta P, Zaytoun, A., Mehta, J. Increase platelet alpha granule release in patients with sickle cell disease in steady state and in those with complications. 1979; 807A.
    322. Mehta P, Zaytoun, A. Increased beta-thromboglobulin release in sickle cell disease patients. 1979; 252A.
    323. Setzer, E., Webb, I., Mehta, P., Kane, J., Rossley, K., Eitzman, D. Maturation of platelet function in preterm infants. 1979; 807A.
    324. Mehta, J., Mehta, P., Pepine, C.J. Modification of coronary venous platelet aggregation by aspirin at rest and during stress. 1979; 187A.
    325. Mehta P, Mehta J, Miale TD, Burger C. Platelet aggregation and circulating platelet aggregates in sickle cell disease patients. 1979; 816A.
    326. Setzer, E., Blake, M., Rossley, K., Mehta, P., Eitzman, D. Platelet of hypofunction in preterm infants. 1979.
    327. Mehta, J., Mehta, P. Enhanced platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and thromboxane A2 in angina pectoris. 1979; 771A.
    328. Mehta, J., Mehta, P., Pepine, C., Feldman, R., Conti, C. Effect of aspirin and dipyridamole on platelet function across the myocardial vascular bed in coronary disease patients. 1979; 729A.
    329. Mehta, J., Smedresman (Mehta), P., Pepine, C.J. The role of propranolol on platelet aggregation during experimental tachycardia stress in man. 1978; 146.
    330. Mehta J, Mehta P, Pepine CJ. Studies upon coronary venous platelet aggregation in coronary artery disease. Effect of aspirin. 1978; 252A.
    331. Mehta P, Miale, T., Burger, C., Barbosa, U., Dearth, J. Significance of circulating platelet aggregates in sickle cell disease patients. 1978; 168.
    332. Mehta, J., Mehta P, Burger, C., Miale, T., Conti, C.R., Pepine, C.J., Nichols, W.W. Platelet aggregration responses across normal forearm vascular bed. Effect of transintischemia. 1978; 70.
    333. Mehta J, Mehta P, Pepine CJ. Platelet aggregation studies in coronary artery disease: IV. Effect of aspirin. Atherosclerosis. 1978; 31:169-175.
    334. Pepine, C.J., Mehta, J., Mehta, P. Alterations of platelet function as platelets traverse the myocardial vascular bed. Effect of aspirin. 1978; II-147.
    335. Vasa R, Smedresman (Mehta) P, Perlman R, Karpatkin M, Newmann LL. Experience with neonatal thrombocytopenia. 1977; 544.
    336. Smedresman (Mehta) P, Piomelli S. A simple technique for electronic counting and sizing platelets. 1977; 481.
    337. Smedresman (Mehta) P, Piomelli S. Electronic platelet counting and sizing on a micro-density gradient. International Congress of Hematology. 1976; p 369.
    Mehta's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (313) concept(s)
    _
    Co-Authors Expand Description
    See all (14) people
    _
    Similar People Expand Description
    See all (27) people
    _
    Same Department Expand Description
    Search Department